Key result
Combined antitumor treatment for triple-negative breast cancer was associated with long-term ECG changes at 2.5-3 years, particularly in patients who received additional radiation therapy.
Why the study?
Anticancer treatments for breast cancer increase survival but also increase cardiovascular disease, prompting the evaluation of ECG changes 2.5—3 years after combined therapy.
Does combined anticancer treatment cause long-term ECG changes in patients with triple-negative breast cancer?
Observational (n=63)
Does combined anticancer treatment cause long-term ECG changes in patients with triple-negative breast cancer?
Answers are grounded in this paper and cite their sources.
Combined anticancer treatment for breast cancer, particularly when including radiation therapy, is associated with long-term ECG changes and an increased risk of cardiovascular complications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kazantseva et al. (2021) conducted an observational in Triple-negative breast cancer (n=63). Combined antitumor treatment (polychemotherapy + surgery +/- radiation therapy) was evaluated on ECG changes. Combined antitumor treatment for triple-negative breast cancer was associated with long-term ECG changes at 2.5-3 years, particularly in patients who received additional radiation therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: